TNF Pharmaceuticals, Inc. Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
TNF Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • TNF Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -87.8 %, a 53% decline year-over-year.
  • TNF Pharmaceuticals, Inc. annual Return On Assets for 2023 was -17.1 %, a 77.7% increase from 2022.
  • TNF Pharmaceuticals, Inc. annual Return On Assets for 2022 was -76.8 %, a 20.9% increase from 2021.
  • TNF Pharmaceuticals, Inc. annual Return On Assets for 2021 was -97.2 %, a 33.6% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -17.1 +59.7 +77.7% Jan 1, 2023 Dec 31, 2023
2022 -76.8 +20.3 +20.9% Jan 1, 2022 Dec 31, 2022
2021 -97.2 -24.4 -33.6% Jan 1, 2021 Dec 31, 2021
2020 -72.7 -18.8 -34.8% Jan 1, 2020 Dec 31, 2020
2019 -54 +46.3 +46.2% Jan 1, 2019 Dec 31, 2019
2018 -100 +3.43 +3.31% Jan 1, 2018 Dec 31, 2018
2017 -104 -46.8 -82.1% Jan 1, 2017 Dec 31, 2017
2016 -57 +20.7 +26.7% Jan 1, 2016 Dec 31, 2016
2015 -77.7 -59.4 -326% Jan 1, 2015 Dec 31, 2015
2014 -18.2 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.